| Dr Shae Bryan Paschal, DPM | |
|
3050 S Center St, Suite 140, Arlington, TX 76014-2022 | |
| (817) 557-1006 | |
| (817) 557-2000 |
| Full Name | Dr Shae Bryan Paschal |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 18 Years |
| Location | 3050 S Center St, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942431341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 9537 (Florida) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1904 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Mansfield Medical Center | Mansfield, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dharmesh Bhakta, Dpm, Pa | 1052375128 | 5 |
News Archive
Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data.
Men who had silent, or symptomless, coronary artery disease (CAD) and type 2 diabetes were nine times as likely to have erectile dysfunction (ED) as were diabetic men who did not have silent heart disease.
The Alabama Supreme Court today overturned a jury verdict against Novartis Pharmaceuticals Corporation (NPC), and directed entry of judgment in favor of NPC. NPC is pleased that the Alabama Supreme Court has found in our favor, which demonstrates that the State of Alabama's claims were unfounded.
Marked by cartilage and bone degradation, progressive knee osteoarthritis (OA) is believed to result in part from a combination of several local mechanical factors. Lack of joint stability, poor joint alignment and injuries to the disks of meniscal tissue that cushion the knee all affect load distribution and the toll to the vulnerable OA knee.
› Verified 8 days ago
| Provider Name | Dharmesh Bhakta, Dpm, Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114051463 PECOS PAC ID: 1052375128 Enrollment ID: O20050303001070 |
News Archive
Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data.
Men who had silent, or symptomless, coronary artery disease (CAD) and type 2 diabetes were nine times as likely to have erectile dysfunction (ED) as were diabetic men who did not have silent heart disease.
The Alabama Supreme Court today overturned a jury verdict against Novartis Pharmaceuticals Corporation (NPC), and directed entry of judgment in favor of NPC. NPC is pleased that the Alabama Supreme Court has found in our favor, which demonstrates that the State of Alabama's claims were unfounded.
Marked by cartilage and bone degradation, progressive knee osteoarthritis (OA) is believed to result in part from a combination of several local mechanical factors. Lack of joint stability, poor joint alignment and injuries to the disks of meniscal tissue that cushion the knee all affect load distribution and the toll to the vulnerable OA knee.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shae Bryan Paschal, DPM 3050 S Center St, Suite 140, Arlington, TX 76014-2022 Ph: (817) 557-1006 | Dr Shae Bryan Paschal, DPM 3050 S Center St, Suite 140, Arlington, TX 76014-2022 Ph: (817) 557-1006 |
News Archive
Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data.
Men who had silent, or symptomless, coronary artery disease (CAD) and type 2 diabetes were nine times as likely to have erectile dysfunction (ED) as were diabetic men who did not have silent heart disease.
The Alabama Supreme Court today overturned a jury verdict against Novartis Pharmaceuticals Corporation (NPC), and directed entry of judgment in favor of NPC. NPC is pleased that the Alabama Supreme Court has found in our favor, which demonstrates that the State of Alabama's claims were unfounded.
Marked by cartilage and bone degradation, progressive knee osteoarthritis (OA) is believed to result in part from a combination of several local mechanical factors. Lack of joint stability, poor joint alignment and injuries to the disks of meniscal tissue that cushion the knee all affect load distribution and the toll to the vulnerable OA knee.
› Verified 8 days ago
Yvette Elaine Forbes-baker, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 107 E Park Row Dr, Arlington, TX 76010 Phone: 817-459-1400 Fax: 817-459-1401 | |
Jones Thomas, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3600 Matlock Rd Ste 104, Arlington, TX 76015 Phone: 817-200-4113 | |
Lewis Podiatry Group Arlington, Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5201 S Cooper St, Suite 121, Arlington, TX 76017 Phone: 817-468-7100 | |
Accent Podiatry Associates Podiatrist Medicare: Medicare Enrolled Practice Location: 3050 S Center St Ste 140, Arlington, TX 76014 Phone: 817-557-1006 Fax: 817-557-2000 | |
Kevin Q Nguyen-khoa Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 1327 E Pioneer Pkwy, Arlington, TX 76010 Phone: 817-265-1595 | |
Dr. Parth J Bhakta, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3050 S Center St Ste 140, Arlington, TX 76014 Phone: 817-557-1006 Fax: 817-557-2000 | |
Dr. Kevin Nguyen-khoa, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1327 E Pioneer Pkwy, Arlington, TX 76010 Phone: 817-265-1595 |